«Dectin-1 embraces Candida glabrata» – Virulence – Noviembre 2017 – Carlos Del Fresno Sánchez 1 Abstract No abstract available Read more Categorías: Publications, Trained ImmunityPor Carlos del Fresnonoviembre 17, 2017Deja un comentarioEtiquetas: Candida glabratadectin-1fungal infectionsmacrophageNavegación entre publicacionesAnteriorPublicación anterior:Neutrophils acROSs the Enemy LinesSiguientePublicación siguiente:Flexible Signaling of Myeloid C-Type Lectin Receptors in Immunity and InflammationRelated PostsEndotoxin tolerance and trained immunity: breaking down immunological memory barriersmayo 1, 2024Heat-killed Mycobacterium tuberculosis induces trained immunity in vitro and in vivo administered systemically or intranasallyenero 31, 2024Intravenous administration of BCG in mice promotes natural killer and T cell-mediated antitumor immunity in the lungoctubre 9, 2023mRNA-1273 boost after BNT162b2 vaccination generates comparable SARS-CoV-2-specific functional responses in naïve and COVID-19-recovered individualsabril 24, 2023Novel intravesical bacterial immunotherapy induces rejection of BCG-unresponsive established bladder tumorsjulio 1, 2022Prior SARS-CoV-2 infection balances immune responses triggered by four EMA-approved COVID-19 vaccines: An observational studymayo 15, 2022
Heat-killed Mycobacterium tuberculosis induces trained immunity in vitro and in vivo administered systemically or intranasallyenero 31, 2024
Intravenous administration of BCG in mice promotes natural killer and T cell-mediated antitumor immunity in the lungoctubre 9, 2023
mRNA-1273 boost after BNT162b2 vaccination generates comparable SARS-CoV-2-specific functional responses in naïve and COVID-19-recovered individualsabril 24, 2023
Novel intravesical bacterial immunotherapy induces rejection of BCG-unresponsive established bladder tumorsjulio 1, 2022
Prior SARS-CoV-2 infection balances immune responses triggered by four EMA-approved COVID-19 vaccines: An observational studymayo 15, 2022
